Low concentrations of calmodulin antagonists caused a small but significant increase in the maximal binding (Borax), but upon a further increase of the concentration, a significant decrease in Bmax was observable; the apparent dissociation constant for the ligand receptor complexes increased with the increase in the concentration of calmodulin antagonists.
From the Scatchard plots, the effects of these compounds on the binding of [3H]DALAMID were biphasic.
Low concentrations of calmodulin antagonists caused a small but significant increase in the maximal binding (Borax), but upon a further increase of the concentration, a significant decrease in Bmax was observable; the apparent dissociation constant for the ligand receptor complexes increased with the increase in the concentration of calmodulin antagonists.
TI 233 (1-30X10-6 M) inhibited, somewhat in a ligand selective manner, the binding of [3H]opioid ligands that have been thought to be selective for opioid receptor types.
Calmodulin antagonists caused to increase in the fluorescence anisotropy obtained from 1,6-diphenyl -1,3,5-hexatriene-labeled membrane fractions from rat brains, indicating that these compounds were effective for the decrease in the membrane fluidity. The present results indicate that putative calmodulin antagonists can affect the binding of the opioid ligands to rat brain membranes, probably through a mechanism other than one involving calmodulin related processes.
It has been reported that a close relation ship exists between the in vivo action of morphine and Ca2+ in the brain (1) (2) (3) (4) (5) (6) was determined in the presence of 10-6 M unlabeled ligand. The binding reaction was terminated by the rapid filtration through Whatman GF/B glass filters. The filter discs were washed under vacuum, twice with 2.5 ml of ice cold 50 mM Tris-HCI buffer solution (pH 7.5) and once more with 5 ml of the same buffer solution, and then they were dried and counted in a liquid scintillation spectrophotometer (Beckman).
The filtration was performed within 30 sec. All of the assays were carried out in duplicate. 
Results
The concentration-inhibition curves and IC50 values for putative calmodulin an tagonists on the specific binding of [3H] DALAMID (2X10-9 M) to rat brain mem branes are shown in Fig. 1 . The specific binding was inhibited by these compounds in a dose-dependent manner. Chlorpromazine was the most potent inhibitor among them. The order of potency of inhibiting the specific binding of [3H]DALAMID was chlor promazine, W-7, TI 233 and trifluoperazine (Legend in Fig. 1 ). Figure 2 shows that the inhibitory effect of calmodulin antagonists is not necessarily specific for Cat+. Fur thermore, these effects seemed independent of free Ca2+ concentrations (IC50 values of TI 233 were 1.1±0.7x10-5 M for 10-4 M CaC12 and 2.0±0.7x10-5 M for 10-7 M CaC12 in the presence of 5 mM EGTA (figures not shown)), and this inhibition was not influenced by exogenously added bovine brain calmodulin (up to 10 ;cg/ml).
Next the effect of calmodulin antagonists on the binding of [3H]DALAMID were analyzed from the Scatchard plots. for BmaX and Fig. 4B for Kd. In these experi ments, the level of the nonspecific binding was not influenced by calmodulin antagonists. Figure 4A shows 7A) . However, these compounds (10-7 10-4 M) had no significant effect on the steady state anisotropy (r,) (Fig. 7B) . •, control (without compounds); 0, chlorpromazine; U, W-7; 0, TI 233; V, trifluoperazine. r, values were calculated according to the formula described in "Materials and Methods".
Each point represents the mean from 3 different measurements. /, chlorpromazine; n, TI 233. With the antago nists examined, the order of inhibitory potency for the binding of [3H]DALAMID (2x10-9 M) was chlorpromazine, W-7, TI 233 and trifluoperazine. This is the reverse of the order for the inhibition of the calmodulin activation of several kinds of enzymes, e.g., cyclic GMP phosphodiesterase from human aortic smooth muscle, Cat'-dependent actomyosin ATPase and protein kinase from chicken gizzard (17). On the other hand, it may be significant that chlorpromazine was more potent than TI 233 in producing an increase in the microviscosity of the phos pholipid bilayers (Fig. 8) .
Recently, Bodine and Tupper (25) On the other hand, it seems that there are apparent inconsistencies between the results of Fig. 7 and Fig. 8 . Figure 7A shows that chlorpromazine and TI 233 distinctly interact with purified synaptosomal fractions. From the structural point of view, biological membranes are constructed by several complex and diverse macromolecules, and they are not simple like phospholipid liposomes.
The com plexity and diversity of biological membranes are thought to reduce the effect of TI 233 and chlorpromazine on the fluorescence anisotropy (Fig. 7A) . Now we think that the characteristics of these compounds on phos pholipid liposomes are also effective on biological membranes, although the proof of this is difficult to obtain in the present study. The apparent dissociation constants were also changed by these antagonists (Fig. 4B) , and the maximal values of BmaX were found with the concentrations of antagonists that were the most effective in producing a change in K(, (Fig. 4, A and B) . This seems similar to the effect of the change in the membrane fluidity on the activity of membrane-bound enzymes (27), in which the contribution of the membrane fluidity was demonstrated using enzymes reconstituted into several kinds of phospholipid liposomes.
The following question is raised: why is the binding capacity of [3H]DALAMID to rat brain membranes enhanced more than 8 nM [3H]DALAMID in the presence of a low concentration of TI 233 (Fig. 3) . It is known that the clustering of opioid receptors is observable by the binding of enkephalins to their receptors (28). It may be thought that the TI 233 modulates the lipid microviscosity around receptors to promote the clustering of opiate receptors, and this clustering causes the ligands to bind to the receptors co operatively.
The effect of TI 233 on BmaX for several [3H]opioid ligands seems to be somewhat ligand-selective (Fig. 6) . DAGO, DADL and EKC have been thought to be selective for ~~ 6 and 'c-type of opioid receptors, respectively (23). If the ratio among the values of BmaX for these three ligands reflect the number distribution of each receptor type per mg protein in rat brain membranes, it is expected that the distribution of receptor types will be changed by TI 233. TI 233 is a lipophylic agent (data not shown) and interacts with membrane phospholipid bilayers to cause the increase of membrane fluidity (Fig. 8) . In the present study , we could not elucidate the relationship between the results of Simantov et al. (10) and ours , but it may result from differences between the experimental systems.
The present results suggest that the binding affinity of opioid ligands to receptors may be influenced by the membrane fluidity and that changes in membrane lipid fluidity (microviscosity) can influence the number distribution of receptor types. Objectively, it does appear, however, that all that can be justifiably said at the present is that a membrane with fluid lipid components is required for the binding activity of opioid receptors. As was reported for phenothiazine antagonists (13-15), TI 233 has also been reported to show many pharmacological actions which are thought not to be cal modulin-related processes; a possible non competitive Ca2+ antagonist for smooth muscles (12, 29), the inhibition of trans mitter release from neuronal cells by blocking the entry of Ca2+ to the cytoplasm (30) , and the inhibition of glutamate induced synaptic current as an open channel blocker (31) .
Although the effects of TI 233 on the binding of [3H]opioid ligands to rat brain membranes apparently seem to be ligand selective (Fig. 7) , it is reasonable to think that these effects of calmodulin antagonists are less specific pharmacological actions. However, the present results will suggest a mechanism by which the receptor types of opioid ligands are observable.
